A Imhof

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi request reprint Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study
    Alexander Imhof
    Department of Internal Medicine, Medical Clinic B, University Hospital, Zurich, Switzerland
    Clin Infect Dis 36:943-51. 2003
  2. pmc Acute severe anaemia in an elderly patient with hereditary sphaerocytosis
    A Imhof
    Department of Medicine, Regionalspital, Langenthal, Switzerland
    Postgrad Med J 79:244, 246. 2003
  3. doi request reprint Fatal outcome after heart transplantation caused by Aspergillus lentulus
    A Zbinden
    Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
    Transpl Infect Dis 14:E60-3. 2012
  4. ncbi request reprint Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring
    Alexander Imhof
    Department of Internal Medicine, University Hospital, Zurich, Switzerland
    Swiss Med Wkly 136:739-42. 2006
  5. ncbi request reprint Caspofungin versus liposomal amphotericin B for empirical therapy
    Markus Schneemann
    N Engl J Med 352:410-4; author reply 410-4. 2005
  6. ncbi request reprint Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay
    S Arunmozhi Balajee
    Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N D3 100, Seattle, WA 98109, USA
    J Antimicrob Chemother 55:102-5. 2005
  7. ncbi request reprint Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
    Alexander Imhof
    Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Clin Infect Dis 39:743-6. 2004
  8. pmc New methods to assess susceptibilities of Aspergillus isolates to caspofungin
    Alexander Imhof
    Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    J Clin Microbiol 41:5683-8. 2003
  9. ncbi request reprint Nephrotoxicity of cyclosporine A and amphotericin B-deoxycholate as continuous infusion in allogenic stem cell transplantation
    Katrin Furrer
    Department of Medicine, University Hospital of Zurich, Switzerland
    Swiss Med Wkly 132:316-20. 2002
  10. ncbi request reprint Fusarium infection in hematopoietic stem cell transplant recipients
    Marcio Nucci
    University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
    Clin Infect Dis 38:1237-42. 2004

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study
    Alexander Imhof
    Department of Internal Medicine, Medical Clinic B, University Hospital, Zurich, Switzerland
    Clin Infect Dis 36:943-51. 2003
    ..In conclusion, continuous infusion of AmB-d escalated to 2.0 mg/kg/day seems not to cause additional impairment of vital organ functions and to be well tolerated by most patients...
  2. pmc Acute severe anaemia in an elderly patient with hereditary sphaerocytosis
    A Imhof
    Department of Medicine, Regionalspital, Langenthal, Switzerland
    Postgrad Med J 79:244, 246. 2003
  3. doi request reprint Fatal outcome after heart transplantation caused by Aspergillus lentulus
    A Zbinden
    Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
    Transpl Infect Dis 14:E60-3. 2012
    ..This is the first report, to our knowledge, of a proven pulmonary invasive fungal infection caused by A. lentulus after heart transplantation...
  4. ncbi request reprint Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring
    Alexander Imhof
    Department of Internal Medicine, University Hospital, Zurich, Switzerland
    Swiss Med Wkly 136:739-42. 2006
    ..Voriconazole shows a considerable interpatient variation of serum concentrations...
  5. ncbi request reprint Caspofungin versus liposomal amphotericin B for empirical therapy
    Markus Schneemann
    N Engl J Med 352:410-4; author reply 410-4. 2005
  6. ncbi request reprint Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay
    S Arunmozhi Balajee
    Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N D3 100, Seattle, WA 98109, USA
    J Antimicrob Chemother 55:102-5. 2005
    ..We have investigated the use of a viability dye, chloromethylfluorescein di-acetate (CMFDA), for antifungal susceptibility testing in a fluorescence microplate (FM) assay format...
  7. ncbi request reprint Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
    Alexander Imhof
    Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Clin Infect Dis 39:743-6. 2004
    ..Minimal inhibitory concentrations were > or =1 microg/mL for all available isolates. Yeasts and molds with decreased susceptibility to voriconazole may cause invasive infection in patients treated successfully for aspergillosis...
  8. pmc New methods to assess susceptibilities of Aspergillus isolates to caspofungin
    Alexander Imhof
    Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    J Clin Microbiol 41:5683-8. 2003
    ..Agar dilution is simple and reproducible, and results were consistent with the results of more technically demanding techniques. This method may be appropriate for use in the clinical laboratory...
  9. ncbi request reprint Nephrotoxicity of cyclosporine A and amphotericin B-deoxycholate as continuous infusion in allogenic stem cell transplantation
    Katrin Furrer
    Department of Medicine, University Hospital of Zurich, Switzerland
    Swiss Med Wkly 132:316-20. 2002
    ..The combined administration of these drugs is frequent in patients with haematological diseases undergoing allogeneic stem cell transplantation...
  10. ncbi request reprint Fusarium infection in hematopoietic stem cell transplant recipients
    Marcio Nucci
    University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
    Clin Infect Dis 38:1237-42. 2004
    ..The actuarial survival was 13% (median, 13 days). Persistent neutropenia was the single prognostic factor for death identified by multivariate analysis...
  11. pmc Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals
    S Arunmozhi Balajee
    Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Antimicrob Agents Chemother 48:1197-203. 2004
    ..These data suggest the potential presence of a genetically unique, poorly sporulating variant of A. fumigatus that demonstrates decreased susceptibilities to several antifungals...
  12. pmc Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Zurich, Switzerland (2003): prevalence of type IV SCCmec and a new SCCmec element associated with isolates from intravenous drug users
    Wei Qi
    Department of Medical Microbiology, University of Zurich, CH 8006 Zurich, Switzerland
    J Clin Microbiol 43:5164-70. 2005
    ..This suggests the presence of novel SCCmec types in MRCNS and no extensive interspecies SCCmec transfer between MRSA and MRCNS...
  13. pmc Aspergillus ustus infections among transplant recipients
    Anil A Panackal
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Emerg Infect Dis 12:403-8. 2006
    ..Based on the clustering of cases in space and time and molecular data, common-source acquisition of this unusual drug-resistant species is possible...
  14. ncbi request reprint Treatment options of invasive fungal infections in adults
    Ursula Fluckiger
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Basel, Switzerland
    Swiss Med Wkly 136:447-63. 2006
    ..Amphotericin B deoxycholate is recommended as initial therapy for the empirical therapy in patients with neutropenia and persistent fever with close monitoring of adverse events...
  15. doi request reprint Determinants of inter-individual cholesterol level variation in an unbiased young male sample
    Frank Jakobus Rühli
    Institute of Anatomy, University of Zurich, Zurich, Switzerland
    Swiss Med Wkly 138:286-91. 2008
    ..We present total cholesterol values and their possible aetiological factors of young Swiss conscripts. Particularly, we study varying impact of these factors depending on different levels of individual cholesterol...
  16. ncbi request reprint Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /l
    Milos Opravil
    Division of Infectious Diseases, University Hospitals of Zurich, Switzerland
    AIDS 16:1371-81. 2002
    ..To evaluate the efficacy of early initiation of highly active antiretroviral therapy (HAART), we compared the clinical course of two nested, matched cohorts within the Swiss HIV Cohort Study...